AIStartups

Metagenomi Slashes AI Costs by 56% Using AWS Custom Chips for Gene-Editing Research

Biotechnology company Metagenomi has significantly cut computing costs while accelerating drug discovery using AWS’s custom AI chips, according to reports. The startup’s AI-powered search for gene-editing enzymes reportedly costs 56% less than previous Nvidia-based systems.

AI-Powered Gene Editing Breakthrough

Gene editing startup Metagenomi has achieved substantial cost savings in its artificial intelligence operations by switching to Amazon Web Services’ custom silicon, according to company statements. Sources indicate the biotech firm reduced its AI computing expenses by 56 percent compared to previous Nvidia GPU-based systems while accelerating the discovery of potential life-saving therapies.